Prostate cancer – sequencing of systemic treatment of systemic disease – case report

02/2021

MUDr. Nikol Rušarová; MUDr. Hana Študentová, Ph.D.

Onkologická klinika LF UP a FN Olomouc

SUMMARY

Prostate cancer is one of the most common cancers in men worldwide. Many patients have and advanced disease despite of early diagnosis. Finding the optimal treatment sequencing in advanced prostate cancer is currently one of the most common question.

Key words

sequencing, prostate cancer, abiraterone, enzalutamide